期刊文献+

糖尿病视网膜病变患者血管内皮生长因子的测定及意义

Detecting and significance of vascular endothelial growth factor in patients with diabetic retinopathy
下载PDF
导出
摘要 目的探讨血管内皮生长因子与非胰岛素依赖型糖尿病患者视网膜病变之间的关系。方法采用酶联免疫吸附测定法检测了52例非胰岛素依赖型糖尿病患者,其中31例伴DR,21例不伴视网膜病变和36例正常对照者血管内皮生长因子含量。结果各组糖尿病患者血管内皮生长因子值显著高于正常对照组(P<0.01),糖尿病无视网膜病变组、背景型及增殖型之间的血管内皮生长因子水平亦显著不同。结论血管内皮生长因子水平与糖尿病视网膜病变的病变程度密切相关。定期测定糖尿病人血中血管内皮生长因子可作为了解糖尿病视网膜病变程度的参考指标。 Objective To study the relationship between vascular endothelial growth factor (VEGF)in the patho- genesis of type 2 diabetes mellitus with retinopathy. Methods VEGF level was measured by enzyme linkedimmunosor- bent assay (ELISA) in of 36 control subjects and 52 patients with type 2 diabetes mellitus consisting of 31 eases of with diabetic retinopathy(DR) as well as 21 eases without retinopathy(NDR). Results There were significantly differences in VEGF level between those of the normal control and retinopathy groups( P 〈 0.01 ). Level of VEGF was significantly differences among groups of NDR, BDR and PDR. Conclusions There is a positive correlation between DR and serum VEGF level in patients with diabetes mellitus, regularmonitor of serum VEGF level can be used as an important index of diabetic retinopathy.
作者 王福玉
出处 《医学信息(内.外科版)》 2009年第8期727-728,共2页 Medical Information Operations Sciences Fascicule
关键词 糖尿病视网膜病变 血管内皮生长因子 酶联免疫吸附测定法 diabetic retinopathy vascular endothelial growth factor ELISA
  • 相关文献

参考文献6

二级参考文献59

  • 1中华医学会眼科学会眼底病学组.糖尿病视网膜病变分期标准[J].眼底病,1985,1:42-42.
  • 2李风鸣.眼科全书.第1版.北京:人民卫生出版社 1996:2326
  • 3Ferrara N,Gerber HP,LeCouter J.The biology of VEGF and its receptors[J].Nat Med 2003; 9 (6):669-676.
  • 4Caldwell RB,Bartoli M,Behzadian MA,El-Remessy AE,AL-habrawey M,Platt DH.Vascular endothelial growth factor and diabetic retinopathy:pathophysiological mechanisms and treatment perspectives[J].Diabetes Metab Res Rev 2003;19 (6):442-455.
  • 5Gilbert RE,Vranes D,Berka JL,Kelly DJ,Cox A,Wu LL,et al.Vascular endothelial growth factor and its receptors in control and diabetic rat eyes[J].Lab Invest 1998; 78(8):1017-1027.
  • 6Funatsu H,Yamashita H,Nakanishi Y,Hori S.Angiotensin Ⅱ and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy[J].Br J Ophthalmol 2002;86(3):311-315.
  • 7Tolentino MJ,McLeod DS,Taomoto M,Otsuji T,Adamis AP,Lutty GA.Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate[J].Am J Ophthalmol 2002; 133(3):373-385.
  • 8Okamoto T,Yamagishi S,Inagaki Y,Amano S,Koga K,Abe R,et al.Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin[J].FASEB J 2002; 16(14):1928-1930.
  • 9Hogeboom van Buggenum IM,Polak BC,Reichert-Thoen JW,de Vries-Knoppert WA,van Hinsbergh VW,Tangelder GJ.Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy[J].Diabetologia 2002;45 (2):203-209.
  • 10Zhang X,Lassila M,Cooper ME,Cao Z.Retinal expression of vascular endothelial growth factor is mediated by angiotensin type 1 and type 2 receptors[J].Hypertension 2004;43(2):276-281.

共引文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部